RNA-directed therapy for C9ORF72-linked ALS using engineered zinc finger nucleases
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110323
- Recipient
-
University Of California, San Diego UEI UYTTZT6G9DT1
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $694,650
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- La Jolla, CA 92093, USA
Award details come from USAspending.gov.
About this award
The University of California, San Diego received a $694,650 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420).
The two-year award will support research on RNA-directed therapy for amyotrophic lateral sclerosis (ALS) linked to the C9ORF72 gene using engineered zinc finger nucleases. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research, including investigating medical solutions for battlefield injuries. This award will advance those goals by funding preclinical development of a potential genetic therapy for a form of ALS with military relevance.
Quick answers
Who received award W81XWH2110323?
W81XWH2110323 was awarded to University Of California, San Diego by Medical Command (Department of the Army) on April 15, 2021.
How much is award W81XWH2110323 worth?
$694,650 has been obligated on W81XWH2110323.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award